peramivir
Sign in to saveAlso known as BCX-1812, 3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic acid, BCX 1812, BCX1812, RWJ 270201, RWJ270201, RWJ-270201, peramivir anhydrous
thumb|Exterior of Rapiacta I.V. Bag 300mg (Generic name: Peramivir hydrate). An anti-influenza virus drug administered by intravenous infusion in Japan.
~4 min read
Encyclopedic overview
3 sectionsContents
- History
- References
- External links
thumb|Exterior of Rapiacta I.V. Bag 300mg (Generic name: Peramivir hydrate). An anti-influenza virus drug administered by intravenous infusion in Japan.
Peramivir (trade name Rapivab) is an antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. It is approved for intravenous administration.
Excerpted from Wikipedia’s “peramivir” article, available under the CC BY-SA 4.0 licence.